M&G Investment Management’s Halliburton HAL Stock Holding History

M&G Investment Management’s Portfolio HAL Stock Details HAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-971,209	Closed	-$21.4M	–	599
2021 Q3	$21.4M	Buy	971,209 +794,641	+450%	+$16.3M	0.05%	192
2021 Q2	$4.06M	Buy	+176,568	New	+$3.92M	0.01%	429

Other funds holding HAL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

M&G Investment Management's HAL Position: Q4 2021 in Review

M&G Investment Management sold out of Halliburton (HAL) in Q4 2021, closing a stake of 971,209 shares — an estimated $21.4M sold.

M&G Investment Management first reported a position in HAL in Q2 2021 and held it in 2 quarters. The position peaked at $21.4M in Q3 2021. 731 funds tracked by Wall St. Rank hold HAL as of Q4 2021.

M&G Investment Management reported no remaining Halliburton position as of Q4 2021 after selling out during the quarter.
M&G Investment Management sold 971,209 Halliburton shares in Q4 2021, an estimated $21.4M.
M&G Investment Management first reported a position in Halliburton in Q2 2021 and held it in 2 quarters.
M&G Investment Management's Halliburton position peaked at $21.4M in Q3 2021.
731 funds tracked by Wall St. Rank held Halliburton as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.